| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079244 Mixture of colostrum, probiotic and prebiotic; gastroinitestinal disorders |
| 04/14/2005 | US20050079233 Using plant extracts |
| 04/14/2005 | US20050079167 Surface treated active carbon; controlling particle size, porosity |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | DE19842833B4 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung 2-arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole and 2-Arylalkinylthio-imidazoles as inflammatory inhibitors and inhibitors of cytokine release |
| 04/14/2005 | CA2554954A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/13/2005 | EP1522542A1 Therapeutic or preventive agent for nausea/vomiting |
| 04/13/2005 | EP1522308A1 Use of chlorophyll or analogues for the prevention of cytotoxic effects of dietary heme on the intestinal mucosa |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521779A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 04/13/2005 | EP1521764A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1521597A1 LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL |
| 04/13/2005 | EP1521596A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 04/13/2005 | EP1521588A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 04/13/2005 | EP1521535A1 Improved bulking agent composition |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1335706B1 Process fo r the production of microspheres of pancreatic enzymes with high stability |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1244641B1 Thiazolyl amide derivatives |
| 04/13/2005 | EP1196136B1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/13/2005 | EP1090105B1 Non-embryonic ependymal neural stem cells and method for their isolation |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606544A Bicyclic compound |
| 04/13/2005 | CN1606463A Methods of treating bacterial infections in dogs and cats |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides |
| 04/13/2005 | CN1606440A Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 04/13/2005 | CN1606438A 5HT4 partial agonist pharmaceutical compositions |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1605354A Yang strengthening capsule and its preparation |
| 04/13/2005 | CN1605345A Medicine for stomach disease |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/13/2005 | CN1196671C Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 04/13/2005 | CN1196494C Medicine powder for aphtha of external use |
| 04/13/2005 | CN1196492C Medicine for treating stomach disease |
| 04/13/2005 | CN1196475C Bioavailable dosage form of isotretinoin |
| 04/12/2005 | US6878745 Selective preventives/remedies for progressive lesions after organ damage |
| 04/12/2005 | US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 04/12/2005 | US6878736 Histamine H3 receptor ligands |
| 04/12/2005 | US6878734 Gastrin and cholecystokinin receptor ligands(II) |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878724 Polyarylcarboxamides useful as lipid lowering agents |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2235041C Iodine complexes in powder form |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/12/2005 | CA2108292C Process for preparing hepatitis a (hav) antigens and vaccines |
| 04/07/2005 | WO2005030960A1 Staple type oligonucleotide and drug comprising the same |
| 04/07/2005 | WO2005030955A1 Protein expressed in nk cell |
| 04/07/2005 | WO2005030953A1 Tetrahydrofolate synthase gene |
| 04/07/2005 | WO2005030235A1 Method of processing ginseng for medicinal use and composition |
| 04/07/2005 | WO2005030233A1 Active oxygen scavenging agent and process for producing the same |
| 04/07/2005 | WO2005030214A1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a]PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
| 04/07/2005 | WO2005030198A1 Medicinal composition for treatment for fatty liver or liver disease |
| 04/07/2005 | WO2005013946A3 Methods of treatment inflammatory bowel with lxr agonists |
| 04/07/2005 | WO2005012269A8 Novel azole compound |
| 04/07/2005 | WO2004112756A8 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 04/07/2005 | WO2004002422A3 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/07/2005 | WO2003065981A3 Therapeutic use for lp229, in particular for wound healing |
| 04/07/2005 | US20050075480 Urotensin-II agonists and antagonists |
| 04/07/2005 | US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases |
| 04/07/2005 | US20050075391 Nitric oxide donor composition and method for treatment of anal disorders |
| 04/07/2005 | US20050075385 Substituted thienoimidazoles useful for disease treatment and prevention |
| 04/07/2005 | US20050075371 Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
| 04/07/2005 | US20050075369 Novel form of S-omeprazole |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |
| 04/07/2005 | US20050075339 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075336 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 04/07/2005 | US20050075335 Pharmaceutical composition comprising n((1-n-butyl-4-piperidinyl)methyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation |
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075315 Antitumor agent |
| 04/07/2005 | US20050075311 Improving the health of ruminant animals, increasing milk production in lactating animals, and/or treating and controlling infective diarrhea by the oral administration of an effective amount of an indigestible oligosaccharide of gluco-oligosaccharides and/or isomalto-oligosaccharides; feed additives |
| 04/07/2005 | US20050075269 Substituted benzofuran-2-carboxamides derivatives |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074818 Methods and agents for the diagnosis and therapy of chronically inflammatory intestinal diseases |